News

Pharmabiz2h
Micropep and Corteva announce research collaboration to co-develop next-generation peptide-based biocontrol solutions
Micropep and Corteva announce research collaboration to co-develop next-generation peptide-based biocontrol solutions: Durham, North Carolina Monday, June 23, 2025, 18:00 Hrs [IST ...
Pharmabiz4h
Immuno Cure and PharmaJet partner to advance a novel HIV therapeutic DNA vaccine using needle-free technology in humans
Immuno Cure and PharmaJet partner to advance a novel HIV therapeutic DNA vaccine using needle-free technology in humans: Hong Kong Monday, June 23, 2025, 16:00 Hrs [IST] Immuno Cu ...
Pharmabiz3h
Utopia Therapeutics secures $1.5 mn investment from Whale Tank to advance preclinical development of obesity vaccine
Utopia Therapeutics secures $1.5 mn investment from Whale Tank to advance preclinical development of obesity vaccine: Our Bureau, Bengaluru Monday, June 23, 2025, 17:20 Hrs [IST] ...
Pharmabiz4h
US FDA clears Lomond Therapeutics’ IND application for phase 1 multicenter study of lonitoclax in patients with relapsed/refractory AML
US FDA clears Lomond Therapeutics’ IND application for phase 1 multicenter study of lonitoclax in patients with relapsed/refractory AML: Dover, Delaware Monday, June 23, 2025, 1 ...
Pharmabiz3h
Novo Nordisk GBS walks the talk on inclusion with Pride March and expanded DEIB agenda
Novo Nordisk GBS walks the talk on inclusion with Pride March and expanded DEIB agenda: Our Bureau, Bengaluru Monday, June 23, 2025, 17:45 Hrs [IST] Novo Nordisk Global Business S ...
Pharmabiz4h
Zeno Health scales up physical retail with 75 new stores in Maharashtra with Rs. 30 crore investment
Zeno Health scales up physical retail with 75 new stores in Maharashtra with Rs. 30 crore investment: Our Bureau, Bengaluru Monday, June 23, 2025, 16:15 Hrs [IST] Zeno Health has ...
Pharmabiz3h
Ratio Therapeutics & TerraPower Isotopes ink supply pact for actinium-225 for targeted radiotherapeutics
Ratio Therapeutics & TerraPower Isotopes ink supply pact for actinium-225 for targeted radiotherapeutics: Boston Monday, June 23, 2025, 17:00 Hrs [IST] Ratio Therapeutics Inc. (Ra ...
Pharmabiz7h
Alexion to present seven abstracts, including four oral presentations, from its leading rare neurology portfolio at EAN 2025
Alexion to present seven abstracts, including four oral presentations, from its leading rare neurology portfolio at EAN 2025: Cambridge, UK Monday, June 23, 2025, 13:00 Hrs [IST] ...
Pharmabiz6h
Firefly Neuroscience researchers uncover powerful new way of objectively measuring SCD, MCI, and dementia in Alzheimer's patients
Firefly Neuroscience researchers uncover powerful new way of objectively measuring SCD, MCI, and dementia in Alzheimer's patients: Kenmore, New York Monday, June 23, 2025, 14:00 H ...
Pharmabiz5h
Bio-Thera receives positive CHMP opinion for Usymro, a biosimilar referencing Stelara
Bio-Thera receives positive CHMP opinion for Usymro, a biosimilar referencing Stelara: Guangzhou, China Monday, June 23, 2025, 15:00 Hrs [IST] Bio-Thera Solutions Inc., a commerci ...
Pharmabiz7h
EMA committee recommends approval of Madrigal Pharma’s resmetirom to treat MASH with moderate to advanced liver fibrosis
Conshohocken, Pennsylvania Monday, June 23, 2025, 13:30 Hrs [IST] ...
Pharmabiz9h
Nanoform secures €5 million R&D loan from Business Finland to advance clinical development of nanoapalutamide
Nanoform secures €5 million R&D loan from Business Finland to advance clinical development of nanoapalutamide: Helsinki, Finland Monday, June 23, 2025, 11:00 Hrs [IST] Nanoform ...